Top compounds associated with response to C18orf63

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Erlotinib	gCSI	pan-cancer	AAC	0.04	0.5
mRNA	FQI-2	CTRPv2	pan-cancer	AAC	0.024	0.5
mRNA	ML312	CTRPv2	pan-cancer	AAC	0.055	0.5
mRNA	SR-II-138A	CTRPv2	pan-cancer	AAC	0.023	0.5
mRNA	OSI-027	CTRPv2	pan-cancer	AAC	0.026	0.5
mRNA	Crizotinib	CTRPv2	pan-cancer	AAC	0.023	0.5
mRNA	MS-275	CTRPv2	pan-cancer	AAC	0.023	0.5
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.026	0.5
mRNA	vorinostat:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.025	0.5
mRNA	ifosfamide	CTRPv2	pan-cancer	AAC	-0.039	0.5

Download CSV